Texas Instruments Inc.: Q4 FY2025 earnings call

What management said about Q4 FY2025, from the documents filed with the SEC on 27 January 2026: press release. Guidance figures: 2 new. The quarter’s numbers.

Key takeaways

Revenue up 10% year on year: Revenue was $4,423 million, up 10% from a year earlier and down 7% from the third quarter's $4,742 million. Net income was $1,163 million, down 3%. Source
Diluted EPS down 2%, reduction included: Diluted EPS was $1.27 against $1.30 a year earlier. Management said it included a 6-cent reduction that was not in the original guidance; the prior quarter's reduction was 10 cents. Source
Analog revenue up 14%: Analog revenue was $3,615 million, up 14% from a year earlier and down from $3,729 million in the prior quarter; operating profit was $1,395 million, up 13%. Source
Trailing free cash flow up 96%: Trailing 12-month cash flow from operations was $7,153 million, up 13%; free cash flow was $2,938 million, up 96%, or 16.6% of revenue. Source
Trailing cash returns $6.5 billion: Total cash returned over 12 months was $6,476 million, up 13%: dividends paid were $4,999 million, up 4%, and stock repurchases were $1,477 million, up 59%. Source

“Revenue decreased 7% sequentially and increased 10% from the same quarter a year ago.”
Haviv Ilan, TI's chairman, president and CEO

Guidance

Area	Period	Figure	Against last quarter
Revenue Source	first quarter 2026	$4.32 billion to $4.68 billion	New
Diluted EPS Source	first quarter 2026	$1.22 to $1.48	New

What changed from last quarter

New guidance: First-quarter 2026 revenue and EPS ranges were given in this release, replacing the fourth-quarter ranges in the prior release. Source
New: Haviv Ilan is titled chairman, president and CEO in this release; the prior release gave his title as president and CEO. Source

Results and growth drivers

Revenue up 10% year on year: Revenue was $4,423 million, up 10% from a year earlier and down 7% from the third quarter's $4,742 million. Net income was $1,163 million, down 3%. Source
Diluted EPS down 2%, reduction included: Diluted EPS was $1.27 against $1.30 a year earlier. Management said it included a 6-cent reduction that was not in the original guidance; the prior quarter's reduction was 10 cents. Source
Full-year revenue and profit rose: Full-year 2025 revenue was $17,682 million against $15,641 million, operating profit $6,023 million against $5,465 million, and diluted EPS $5.45 against $5.20. Source
Results within prior guidance ranges: Fourth-quarter revenue of $4,423 million fell within the $4.22 billion to $4.58 billion range given in the prior release; diluted EPS of $1.27 fell within the prior $1.13 to $1.39 range.

Segment results

Analog revenue up 14%: Analog revenue was $3,615 million, up 14% from a year earlier and down from $3,729 million in the prior quarter; operating profit was $1,395 million, up 13%. Source
Embedded Processing profit up 22%: Embedded Processing revenue was $662 million, up 8%, and operating profit was $71 million, up 22% from $58 million; prior-quarter revenue was $709 million. Source
Other segment profit down 91%: Other revenue was $146 million, down 34%; operating profit was $7 million, down 91%, and includes restructuring charges and other items. Source
Full-year Analog revenue up 15%: For full-year 2025, Analog revenue was $14,006 million, up 15%, and operating profit was $5,412 million, up 17%. Embedded Processing revenue was $2,697 million, up 6%. Source

“Our cash flow from operations of $7.2 billion for the trailing 12 months again underscored the strength of our business model, the quality of our product portfolio and the benefit of 300mm production.”
Haviv Ilan, TI's chairman, president and CEO

Costs, margins and restructuring

Cost of revenue up year on year: Cost of revenue was $1,951 million against $1,693 million a year earlier, and gross profit was $2,472 million against $2,314 million. Source
Gross profit below prior quarter: The prior release reported cost of revenue of $2,019 million and gross profit of $2,723 million on revenue of $4,742 million.
R&D up, SG&A flat year on year: R&D was $521 million against $491 million; SG&A was $446 million in both periods. Full-year R&D was $2,083 million and full-year SG&A was $1,860 million. Source
Restructuring charges lower this quarter: Restructuring charges and other were $32 million, against $85 million in the prior release; the year-earlier quarter had none.

Cash generation and capital spending

Quarterly operating cash flow up: Cash flow from operations was $2,254 million in the quarter, against $1,998 million a year earlier. Source
Trailing free cash flow up 96%: Trailing 12-month cash flow from operations was $7,153 million, up 13%; free cash flow was $2,938 million, up 96%, or 16.6% of revenue. Source
Capital spending lower than last year: Quarterly capital expenditures were $925 million against $1,192 million; trailing capital expenditures were $4,550 million against $4,820 million. Source

Returns to shareholders

Trailing cash returns $6.5 billion: Total cash returned over 12 months was $6,476 million, up 13%: dividends paid were $4,999 million, up 4%, and stock repurchases were $1,477 million, up 59%. Source
Quarterly buybacks $403 million: Stock repurchases were $403 million in the quarter, against $537 million a year earlier; dividends paid were $1,290 million, against $1,240 million. Source
Dividend declared per share $1.42: Cash dividends declared were $1.42 per common share in the quarter, against $1.36 a year earlier; full-year declared dividends were $5.50, against $5.26. Source

Balance sheet and investment

Cash and short-term investments lower: Cash and cash equivalents were $3,225 million and short-term investments were $1,656 million, against $4,380 million of short-term investments a year earlier. Source
Inventories up year on year: Inventories were $4,804 million, against $4,527 million a year earlier and $4,829 million in the prior release. Source
Long-term debt $13.5 billion: Long-term debt was $13,548 million, against $12,846 million a year earlier; the current portion was $500 million, against $750 million. Source
Diluted shares down to 911 million: Diluted average shares were 911 million in the quarter, against 919 million a year earlier; basic average shares were 907 million. Source
R&D and SG&A invested over 12 months: Management said it invested $3.9 billion in R&D and SG&A over the past 12 months. Source
CHIPS Act credit used against tax: Investment tax credit used to reduce income taxes payable was $89 million in the quarter and $335 million for 2025, against $588 million for 2024. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.

As filed with the SEC

Open the filing on EDGAR

TI reports Q4 2025 and 2025 financial results and shareholder returns

Conference call at 3:30 p.m. Central time today on ti.com/ir

DALLAS (Jan. 27, 2026) - Texas Instruments Incorporated (TI) (Nasdaq: TXN) today reported fourth quarter revenue of $4.42 billion, net income of $1.16 billion and earnings per share of $1.27. Earnings per share included a 6-cent reduction that was not in the company's original guidance.

Regarding the company's performance and returns to shareholders, Haviv Ilan, TI's chairman, president and CEO, made the following comments:

"Revenue decreased 7% sequentially and increased 10% from the same quarter a year ago.
"Our cash flow from operations of $7.2 billion for the trailing 12 months again underscored the strength of our business model, the quality of our product portfolio and the benefit of 300mm production. Free cash flow for the same period was $2.9 billion.
"Over the past 12 months we invested $3.9 billion in R&D and SG&A, invested $4.6 billion in capital expenditures and returned $6.5 billion to owners.
"TI's first quarter outlook is for revenue in the range of $4.32 billion to $4.68 billion and earnings per share between $1.22 and $1.48."

Free cash flow, a non-GAAP financial measure, is cash flow from operations less capital expenditures, plus proceeds from U.S. CHIPS and Science Act (CHIPS Act) incentives.

Earnings summary

(In millions, except per-share amounts)	Q4 2025	Q4 2024	Change
Revenue	$4,423	$4,007	10%
Operating profit	$1,473	$1,377	7%
Net income	$1,163	$1,205	(3)%
Earnings per share	$1.27	$1.30	(2)%

Cash generation

		Trailing 12 Months
(In millions)	Q4 2025	Q4 2025	Q4 2024	Change
Cash flow from operations	$2,254	$7,153	$6,318	13%
Free cash flow	$1,329	$2,938	$1,498	96%
Free cash flow % of revenue		16.6%	9.6%

Cash return

		Trailing 12 Months
(In millions)	Q4 2025	Q4 2025	Q4 2024	Change
Dividends paid	$1,290	$4,999	$4,795	4%
Stock repurchases	$403	$1,477	$929	59%
Total cash returned	$1,693	$6,476	$5,724	13%

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

Consolidated Statements of Income	For Three Months Ended December 31,				For Years Ended December 31,
(In millions, except per-share amounts)		2025		2024		2025		2024
Revenue	$4,423		$4,007		$17,682		$15,641
Cost of revenue (COR)	1,951		1,693		7,599		6,547
Gross profit	2,472		2,314		10,083		9,094
Research and development (R&D)	521		491		2,083		1,959
Selling, general and administrative (SG&A)	446		446		1,860		1,794
Restructuring charges/other	32		-		117		(124)
Operating profit	1,473		1,377		6,023		5,465
Other income (expense), net (OI&E)	40		112		230		496
Interest and debt expense	141		130		543		508
Income before income taxes	1,372		1,359		5,710		5,453
Provision for income taxes	209		154		709		654
Net income	$1,163		$1,205		$5,001		$4,799
Diluted earnings per common share	$1.27		$1.30		$5.45		$5.20
Average shares outstanding:
Basic	907		912		909		912
Diluted	911		919		913		919
Cash dividends declared per common share	$1.42		$1.36		$5.50		$5.26
Supplemental Information
Provision for income taxes is based on the following:
Operating taxes (calculated using the estimated annual effective tax rate)	$221		$170		$835		$743
Discrete tax items	(12)		(16)		(126)		(89)
Provision for income taxes (effective taxes)	$209		$154		$709		$654
A portion of net income is allocated to unvested restricted stock units (RSUs) on which we pay dividend equivalents. Diluted EPS is calculated using the following:
Net income	$1,163		$1,205		$5,001		$4,799
Income allocated to RSUs	(7)		(7)		(28)		(24)
Income allocated to common stock for diluted EPS	$1,156		$1,198		$4,973		$4,775

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

Consolidated Balance Sheets	December 31,
(In millions, except par value)		2025		2024
Assets
Current assets:
Cash and cash equivalents	$3,225		$3,200
Short-term investments	1,656		4,380
Accounts receivable, net of allowances of ($22) and ($21)	1,963		1,719
Raw materials	465		395
Work in process	2,372		2,214
Finished goods	1,967		1,918
Inventories	4,804		4,527
Prepaid expenses and other current assets	2,102		1,200
Total current assets	13,750		15,026
Property, plant and equipment at cost	17,682		15,254
Accumulated depreciation	(5,362)		(3,907)
Property, plant and equipment	12,320		11,347
Goodwill	4,330		4,362
Deferred tax assets	967		936
Capitalized software licenses	238		257
Overfunded retirement plans	324		233
Other long-term assets	2,656		3,348
Total assets	$34,585		$35,509
Liabilities and stockholders' equity
Current liabilities:
Current portion of long-term debt	$500		$750
Accounts payable	756		820
Accrued compensation	829		839
Income taxes payable	67		159
Accrued expenses and other liabilities	1,007		1,075
Total current liabilities	3,159		3,643
Long-term debt	13,548		12,846
Underfunded retirement plans	124		110
Deferred tax liabilities	66		53
Other long-term liabilities	1,415		1,954
Total liabilities	18,312		18,606
Stockholders' equity:
Preferred stock, $25 par value. Shares authorized - 10; none issued	-		-
Common stock, $1 par value. Shares authorized - 2,400; shares issued - 1,741	1,741		1,741
Paid-in capital	4,511		3,935
Retained earnings	52,236		52,262
Treasury common stock at cost
Shares: 2025 - 834; 2024 - 830	(42,130)		(40,895)
Accumulated other comprehensive income (loss), net of taxes (AOCI)	(85)		(140)
Total stockholders' equity	16,273		16,903
Total liabilities and stockholders' equity	$34,585		$35,509

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES

Consolidated Statements of Cash Flows	For Three Months Ended December 31,				For Years Ended December 31,
(In millions)		2025		2024		2025		2024
Cash flows from operating activities
Net income	$1,163		$1,205		$5,001		$4,799
Adjustments to net income:
Depreciation	537		416		1,918		1,508
Amortization of capitalized software	20		19		81		72
Stock compensation	81		78		419		387
(Gains) losses on sales of assets	2		(1)		2		(127)
Deferred taxes	115		(21)		(19)		(210)
Increase (decrease) from changes in:
Accounts receivable	99		143		(244)		68
Inventories	25		(231)		(277)		(528)
Prepaid expenses and other current assets	8		76		10		7
Accounts payable and accrued expenses	20		87		77		125
Accrued compensation	106		115		(28)		(12)
Income taxes payable	23		110		191		597
Changes in funded status of retirement plans	7		31		(7)		33
Other	48		(29)		29		(401)
Cash flows from operating activities	2,254		1,998		7,153		6,318
Cash flows from investing activities
Capital expenditures	(925)		(1,192)		(4,550)		(4,820)
Proceeds from CHIPS Act incentives	-		-		335		-
Proceeds from asset sales	-		1		1		195
Purchases of short-term investments	(880)		(909)		(3,524)		(9,716)
Proceeds from short-term investments	1,110		2,726		6,308		11,187
Other	19		(12)		(9)		(48)
Cash flows from investing activities	(676)		614		(1,439)		(3,202)
Cash flows from financing activities
Proceeds from issuance of long-term debt	-		-		1,199		2,980
Repayment of debt	-		(300)		(750)		(600)
Dividends paid	(1,290)		(1,240)		(4,999)		(4,795)
Stock repurchases	(403)		(537)		(1,477)		(929)
Proceeds from common stock transactions	42		87		400		517
Other	(13)		(11)		(62)		(53)
Cash flows from financing activities	(1,664)		(2,001)		(5,689)		(2,880)
Net change in cash and cash equivalents	(86)		611		25		236
Cash and cash equivalents at beginning of period	3,311		2,589		3,200		2,964
Cash and cash equivalents at end of period	$3,225		$3,200		$3,225		$3,200
Supplemental cash flow information
Investment tax credit (ITC) used to reduce income taxes payable	$89		$56		$335		$588
Proceeds from CHIPS Act incentives	-		-		335		-
Total cash benefit related to the CHIPS Act	$89		$56		$670		$588

Quarterly segment results

(In millions)	Q4 2025	Q4 2024	Change
Analog:
Revenue	$3,615	$3,174	14%
Operating profit	$1,395	$1,237	13%
Embedded Processing:
Revenue	$662	$613	8%
Operating profit	$71	$58	22%
Other:
Revenue	$146	$220	(34)%
Operating profit *	$7	$82	(91)%

* Includes Restructuring charges/other

Annual segment results

(In millions)		2025		2024	Change
Analog:
Revenue	$14,006		$12,161		15%
Operating profit	$5,412		$4,608		17%
Embedded Processing:
Revenue	$2,697		$2,533		6%
Operating profit	$304		$352		(14)%
Other:
Revenue	$979		$947		3%
Operating profit *	$307		$505		(39)%

* Includes Restructuring charges/other

Non-GAAP financial information

This release includes references to free cash flow and ratios based on that measure. These are financial measures that were not prepared in accordance with GAAP. Free cash flow is calculated as cash flows from operating activities (also referred to as cash flow from operations) less capital expenditures, plus proceeds from CHIPS Act incentives.

We believe that free cash flow and the associated ratios provide insight into our liquidity, our cash-generating capability and the amount of cash potentially available to return to shareholders, as well as insight into our financial performance. These non-GAAP measures are supplemental to the comparable GAAP measures.

Reconciliation to the most directly comparable GAAP measures is provided in the table below.

	For Three Months Ended December 31,		For 12 Months Ended December 31,
(In millions)		2025		2025		2024	Change
Cash flow from operations (GAAP) *	$2,254		$7,153		$6,318		13%
Capital expenditures	(925)		(4,550)		(4,820)
Proceeds from CHIPS Act incentives	-		335		-
Free cash flow (non-GAAP)	$1,329		$2,938		$1,498		96%
Revenue			$17,682		$15,641
Cash flow from operations as a percentage of revenue (GAAP)			40.5%		40.4%
Free cash flow as a percentage of revenue (non-GAAP)			16.6%		9.6%

* Includes cash benefits of $89 million, $335 million and $588 million from the CHIPS Act ITC used to reduce income taxes payable for the three months ended December 31, 2025, and the twelve months ended December 31, 2025 and 2024, respectively.

This release also includes references to operating taxes, a non-GAAP term we use to describe taxes calculated using the estimated annual effective tax rate, a GAAP measure that by definition does not include discrete tax items. We believe the term operating taxes helps to differentiate from effective taxes, which include discrete tax items.

Notice regarding forward-looking statements

This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as TI or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe TI's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

We urge you to carefully consider the following important factors that could cause actual results to differ materially from the expectations of TI or our management:

Economic, social and political conditions, and natural events in the countries in which we, our customers or our suppliers operate, including global trade policies;
Market demand for semiconductors, particularly in the industrial and automotive markets, and customer demand that differs from forecasts;
Our ability to compete in products and prices in an intensely competitive industry;
Evolving cybersecurity and other threats relating to our information technology systems or those of our customers, suppliers and other third parties;
Our ability to successfully implement and realize opportunities from strategic, business and organizational changes, or our ability to realize our expectations regarding the amount and timing of associated restructuring charges and cost savings;
Our ability to develop, manufacture and market innovative products in a rapidly changing technological environment, our timely implementation of new manufacturing technologies and installation of manufacturing equipment, and our ability to realize expected returns on significant investments in manufacturing capacity;
Availability and cost of key materials, utilities, manufacturing equipment, third-party manufacturing services and manufacturing technology;
Our ability to recruit and retain skilled personnel and effectively manage key employee succession;
Product liability, warranty or other claims relating to our products, software, manufacturing, delivery, services, design or communications, or recalls by our customers for a product containing one of our parts;
Compliance with or changes in the complex laws, rules and regulations to which we are or may become subject, or actions of enforcement authorities, that restrict our ability to operate our business or subject us to fines, penalties or other legal liability;
Changes in tax law and accounting standards that impact the tax rate applicable to us, the jurisdictions in which profits are determined to be earned and taxed, adverse resolution of tax audits, increases in tariff rates, and the ability to realize deferred tax assets;
Financial difficulties of our distributors or semiconductor distributors' promotion of competing product lines to our detriment; or disputes with current or former distributors;
Losses or curtailments of purchases from key customers or the timing and amount of customer inventory adjustments;
Our ability to maintain or improve profit margins, including our ability to utilize our manufacturing facilities at sufficient levels to cover our fixed operating costs, in an intensely competitive and cyclical industry and changing regulatory environment;
Our ability to maintain and enforce a strong intellectual property portfolio and maintain freedom of operation in all jurisdictions where we conduct business; or our exposure to infringement claims;
Instability in the global credit and financial markets; and
Impairments of our non-financial assets.

For a more detailed discussion of these factors, see the Risk factors discussion in Item 1A of TI's most recent Form 10-K. The forward-looking statements included in this release are made only as of the date of this release, and we undertake no obligation to update the forward-looking statements to reflect subsequent events or circumstances. If we do update any forward-looking statement, you should not infer that we will make additional updates with respect to that statement or any other forward-looking statement.

About Texas Instruments

Texas Instruments Incorporated (Nasdaq: TXN) is a global semiconductor company that designs, manufactures and sells analog and embedded processing chips for markets such as industrial, automotive, personal electronics, enterprise systems and communications equipment. At our core, we have a passion to create a better world by making electronics more affordable through semiconductors. This passion is alive today as each generation of innovation builds upon the last to make our technology more reliable, more affordable and lower power, making it possible for semiconductors to go into electronics everywhere. Learn more at TI.com.